Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7794710 Methods of enhancing T cell responsiveness

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 22, 2002
Date of Patent
September 14, 2010
Patent Application Number
10127282
Patent Citations Received
‌
US Patent 12089575 Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
0
‌
US Patent 11939378 Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
0
‌
US Patent 11999740 Fused pyrazine derivatives as A2A / A2B inhibitors
0
‌
US Patent 11708412 Methods for treating hematologic cancers
0
‌
US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies
‌
US Patent 11773175 Antibodies, uses and methods
‌
US Patent 11779604 Antibodies, combinations comprising antibodies, biomarkers, uses and methods
‌
US Patent 11781138 FN3 domain-siRNA conjugates and uses thereof
‌
US Patent 11827704 Antibody molecules to PD-1 and uses thereof
0
‌
US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7794710
Patent Primary Examiner
‌
Ilia Ouspenski

Find more entities like US Patent 7794710 Methods of enhancing T cell responsiveness

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.